Astellas Pharma (OTCMKTS:ALPMY – Get Rating) and Thorne HealthTech (NASDAQ:THRN – Get Rating) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation. Analyst Ratings This is a summary of recent recommendations and […]
Thorne HealthTech (NASDAQ:THRN – Get Rating) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, May 11th. Analysts expect the company to announce earnings of $0.09 per share for the quarter. Thorne HealthTech has set its FY 2022 guidance at EPS.Parties that are interested in registering for the company’s […]
Thorne HealthTech, Inc. (NASDAQ:THRN – Get Rating) Director Saloni S. Varma bought 9,223 shares of the company’s stock in a transaction that occurred on Wednesday, March 23rd. The shares were bought at an average price of $6.01 per share, with a total value of $55,430.23. The acquisition was disclosed in a filing with the Securities […]
Thorne Healthtech (NASDAQ:THRN – Get Rating) posted its earnings results on Monday. The company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.03 by $0.03, Yahoo Finance reports. Thorne Healthtech updated its FY 2022 guidance to EPS. Shares of THRN stock opened at $4.73 on Wednesday. The business’s 50-day moving average price […]